Atlas Trials

Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy

Clinical trial NCT00837330 · COMPLETED

Trial details

NCT number
NCT00837330
Sponsor
Southeast Retina Center, Georgia
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Polypoidal Choroidal Vasculopathy
Start date
2006-05-01
Primary completion
2010-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.